Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Combined Oral Contraceptive Pills on Migraine, a Randomized Controlled Trial

NCT06509503 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06509503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06509503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Combined Oral Contraceptive Pills on Migraine, a Randomized Controlled Trial
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Recruiting
Start date
July 15, 2024
Completion date
July 30, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine